Among Monday’s rekommendations- and price target changes raised an oil company and an engineering group to purchase.
—————– ————————————————– –
Banking:
Annual New (Old)
——————– ————————————————-
ABG Sundal Collier:
Alfa Laval | Buy | (keep) |
BofA Merrill Lynch:
EnQuest | Buy | (Neutral) |
Danske Bank:
Sandvik | Buy, $ 100 | (Buy , 110 kr) |
UBS:
MTG | Neutral | (Buy) |
ABG Sundal Collier raises recommendation for engineering company Alfa Laval to purchase, from previously intact.
Bank of America Merrill Lynch raises recommendation for EnQuest to buy, from the previously neutral.
Sandvik has been trading down in the recent past and Danske Bank expects more estimate cuts are to be expected during the period until the next quarterly report. Continued weak demand in Europe and weak margins in the Mining makes Danske do not see any factors that could support a rise in the short term.
According to a recent newsletter.
At the same time, Danske Bank to today’s valuation multiples are low relative to the company’s historical average and this should provide some support to the share. Hence the repeat purchase recommendation.
UBS lowers recommendation on media company MTG from buy to neutral.
The business world picks in Gunnebo in their portfolio while Volvo and Trelleborg disappears from the portfolio.
Börsveckan recommend the purchase of Bilia and reiterates its buy recommendation for Nobia MedCap and Midsona.
Dagens Industri writes that it’s time to take out huge in Norwegian sports chain XXL listed on the Oslo Stock Exchange on 8 October.
Handelsbanken adds Clas Ohlson and Peab in his small cap list and removes ÅF.
Redeye raises its fair value estimate of Moberg Pharma to SEK 63 from the previous 60.
————————————————- ———————
No comments:
Post a Comment